Fulltext

i-gel™ supraglottic airway in clinical practice: a prospective observational multicentre study

Theiler, L. ; Gutzmann, M. ; Kleine-Brueggeney, M. ; Urwyler, N. ; Kaempfen, B. ; Greif, R.

In: British Journal of Anaesthesia, 2012, vol. 109, no. 6, p. 990-995

Add to personal list
    Title
    • i-gel™ supraglottic airway in clinical practice: a prospective observational multicentre study
    Author
    • Theiler, L.. Department of Anesthesiology, Perioperative Medicine and Pain Management, University of Miami Miller School of Medicine, Gautier Bldg, Room 415, 1011 N.W. 15th Street, Miami, FL 33136, USA
    • Gutzmann, M.. Division of Anaesthesiology, University Hospitals of Geneva, Geneva, Switzerland
    • Kleine-Brueggeney, M.. University Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
    • Urwyler, N.. University Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
    • Kaempfen, B.. Department of Anaesthesiology, Spitalzentrum Oberwallis, Visp, Switzerland
    • Greif, R.. University Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
    Document Type
    • Postprint
    Language
    • English
    Published in
    • British Journal of Anaesthesia, 2012, vol. 109, no. 6, p. 990-995. Oxford University Press
    Other Version
    OAI-PMH Identifier
    • oai:doc.rero.ch:303776
    Summary
    Background The i-gel™ supraglottic airway device has been studied in randomized controlled studies, but it has not been evaluated in a large prospective patient cohort. Therefore, we performed this prospective multicentre observational study to evaluate success rates, airway leak pressure, risk factors for i-gel failure, and adverse events. Methods With Ethics Committee approval and waiver of patients' consent, data about anaesthesia providers, patient characteristics, and the performance of the i-gel were recorded in five independent hospitals in Switzerland over a period of 24 months. We analysed success rates, leak pressures, adverse events, and risk factors for failure. Results Data from 2049 i-gel uses were analysed. Patients' mean age was 47 (range 6-91) yr. The primary i-gel success rate without changing size was 93%; the overall success rate was 96%. Insertion was deemed very easy or easy in 92%. The mean airway leak pressure was 26 (8) cm H2O. The mean anaesthesia time was 67 (42) min. Risk factors associated with i-gel failure were males (P<0.001), impaired mandibular subluxation (P=0.01), poor dentition (P=0.02), and older age (P<0.01). Adverse events recorded were laryngeal spasms (n=25, 1.2%), blood stained airway devices (n=79, 3.9%), transient nerve damage (n=2, 0.1%), one case of transient vasovagal asystole, and one glottic haematoma. Conclusions The i-gel is a reliable supraglottic airway device failing in <5% and providing high airway leak pressures. Males, impaired mandibular subluxation, poor dentition, and older age are risk factors associated with primary device failure. Serious adverse events are rare